Group 6 Copy 509
1
Please wait...

About This Project

The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can we find a low cost solution to store temperature sensitive enzymes in research?

Temperature-sensitive reagents are common in biology labs, and often need to be stored in expensive ultra...

Finding a Cure for Batten Disease

In March of this year, both of our daughters, Charlotte and Gwenyth, were diagnosed with Late Infantile...

Can we noninvasively measure blood sugar for diabetes?

Better management of type 1 diabetes is moving towards anartificial pancreas. However, we need a better...

Backer Badge Funded